An asbestosis prognosis can be determined following diagnosis of the asbestos lung cancer

Cisplatin treatment is often used for malignant mesothelioma patients who are not good candidates for surgery. Malignant mesothelioma usually is advanced by the time it is diagnosed, so the outlook usually is poor. On average, the survival time after diagnosis is about one year.

Prognosis and prognostic factors of malignant Pleuramesothelioms Overall, the prognosis of patients at a Pleuramesotheliom malignant disease, with and without therapy is bad. The median survival time is about 7-10 months from time of diagnosis.

An asbestosis prognosis can be determined following diagnosis of the asbestos lung cancer. While asbestosis itself is non-malignant and not directly fatal, its effects can be associated with eliciting secondary conditions that can result in death. Pleural mesothelioma is a difficult cancer to treat because it can spread so extensively and it is generally not diagnosed early enough. Pleural mesothelioma patients have a poorer prognosis if they are experiencing chest pain, shortness of breath, inability to perform daily tasks, or weight loss.